Michigan Firm Seeks Tax Break to Brew Cancer-Fighting Nivolumab
Published Date: 6/2/2025
Notice
Summary
Grand River Aseptic Manufacturing in Michigan wants to make a special medicine called nivolumab using a key ingredient called atigotatug inside a Foreign-Trade Zone, which means they can save on import taxes. This change affects their Grand Rapids and Caledonia plants and could help them produce medicines more cheaply and quickly. People have until July 14, 2025, to share their thoughts on this plan.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
FTZ production proposed in Michigan
Grand River Aseptic Manufacturing filed a notification to conduct production inside Foreign-Trade Zone (FTZ) 189 at its Grand Rapids and Caledonia, Michigan facilities for the drug nivolumab. The notification was received May 21, 2025 and production under FTZ procedures would be limited to the specific materials and finished product described and authorized by the FTZ Board.
Nivolumab and API listed duty-free
The proposal lists the finished product nivolumab as duty-free and lists the foreign-status material atigotatug (the nivolumab active pharmaceutical ingredient) as duty-free when used in production under FTZ procedures. These duty-free designations are part of the notification submitted to the FTZ Board.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in